FDA Panel Backs Pfizer, Moderna Shots for Children 5 Years and Younger
Panel's recommendations will now go to the FDA, which is expected to approve use of the vaccines this week
Exercise May Boost Immune Response to Flu Vaccine
However, acute exercise does not show benefit for generally inactive people
Veterans Report Low Rates of Adverse Events With mRNA Vaccines
Rates slightly higher at 42 days for those receiving Pfizer versus Moderna
COVID-19 Vaccines Cut Mortality With Heart Failure
Those who are partially vaccinated and unvaccinated face same increased risk, while boosted and fully vaccinated adults fare best
COVID-19 Incidence, Hospitalization Up for Persons With Disabilities
Medicare beneficiaries who are eligible because of disability have higher COVID-19 incidence, hospitalization rates than age-eligible
No Increase Seen in Pediatric Hepatitis in the United States
No increase in acute hepatitis of unspecified etiology, adenovirus types 40/41 above prepandemic baseline levels
WHO Experts to Decide if Monkeypox Is a Global Emergency
Doing so would mean the WHO views the normally rare disease as a continuing threat to nations worldwide
FDA Advisors Back Moderna Shot for Older Children, Teens
Some panel members noted that the vaccine would likely help prevent serious illness but not be as good at blocking mild infections
FDA Panel to Weigh Moderna Vaccine for Those Aged 6 to 17
Regulators have been concerned about reports of myocarditis seen mostly in young men receiving the Moderna vaccine
One Dead, 27 Hospitalized in U.S. Salmonella Outbreak Tied to Poultry
Actual number of sick people is likely much higher than the reported number because many people recover without medical care
